References
- Pathak SM, Musmade P, Dengle S, et al. Enhanced oral absorption of saquinavir with methyl-beta-cyclodextrin – preparation and in vitro and in vivo evaluation. Eur J Pharm Sci 2010;41:440–51
- Yang W, Chow KT, Lang B, et al. In vitro characterization and pharmacokinetics in mice following pulmonary delivery of itraconazole as cyclodextrin solubilized solution. Eur J Pharm Sci 2010;39:336–47
- Kurkov SV, Loftsson T. Cyclodextrins. Int J Pharm 2013;453:167–80
- Lu Y, Park K. Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs. Int J Pharm 2013;453:198–214
- Leleux J, Williams III RO. Recent advancements in mechanical reduction methods: particulate systems. Drug Dev Ind Pharm 2014;40:289–300
- DiNunzio JC, Hughey JR, Brough C, et al. Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol® Dispersing. Drug Dev Ind Pharm 2010;36:1064–78
- Brough C, Williams III RO. Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery. Int J Pharm 2013;453:157–66
- Bennett RC, Brough C, Miller DA, et al. Preparation of amorphous solid dispersions by rotary evaporation and KinetiSol Dispersing: approaches to enhance solubility of a poorly water-soluble gum extract. Drug Dev Ind Pharm. [Epub ahead of print]. doi: 10.3109/03639045.2013.866142
- Laitinen R, Löbmann K, Strachan CJ, et al. Emerging trends in the stabilization of amorphous drugs. Int J Pharm 2013;453:65–79
- Bevernage J, Brouwers J, Brewster ME, Augustijns P. Evaluation of gastrointestinal drug supersaturation and precipitation: strategies and issues. Int J Pharm 2013;453:25–35
- Xu S, Dai W-G. Drug precipitation inhibitors in supersaturable formulations. Int J Pharm 2013;453:36–43
- Elder DP, Holm R, Diego HL. Use of pharmaceutical salts and cocrystals to address the issue of poor solubility. Int J Pharm 2013;453:88–100
- Wang Y, Sun L, Jiang T, et al. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol. Drug Dev Ind Pharm. [Epub ahead of print]. doi: 10.3109/03639045.2013.788013
- Vialpando M, Aerts A, Persoons J, et al. Evaluation of ordered mesoporous silica as a carrier for poorly soluble drugs: influence of pressure on the structure and drug release. J Pharm Sci 2011;100:3411–20
- Xu W, Riikonen J, Lehto V-P. Mesoporous systems for poorly soluble drugs. Int J Pharm 2013;453:181–97
- Kim GG, Poudel BK, Marasini N, et al. Enhancement of oral bioavailability of fenofibrate by solid self-microemulsifying drug delivery systems. Drug Dev Ind Pharm 2013;39:1431–8
- Ali MH, Moghaddam B, Kirby DJ, et al. The role of lipid geometry in designing liposomes for the solubilisation of poorly water soluble drugs. Int J Pharm 2013;453:225–32
- Mu H, Holm R, Müllertz A. Lipid-based formulations for oral administration of poorly water-soluble drugs. Int J Pharm 2013;453:215–24
- Qi S, Marchaud D, Craig DQM. An investigation into the mechanism of dissolution rate enhancement of poorly water-soluble drugs from spray chilled gelucire 50/13 microspheres. J Pharm Sci 2010;99:262–74
- Lee KWY, Porter CJH, Boyd BJ. The effect of administered dose of lipid-based formulations on the In Vitro and In Vivo performance of cinnarizine as a model poorly water-soluble drug. J Pharm Sci 2013;102:565–78
- Paudel A, Worku ZA, Meeus J, et al. Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations. Int J Pharm 2013;453:253–84
- Shah S, Maddineni S, Lu J, Repka MA. Melt extrusion with poorly soluble drugs. Int J Pharm 2013;453:233–52
- Siepmann J, Siepmann F. Mathematical modeling of drug dissolution. Int J Pharm 2013;453:12–24
- Duret C, Wauthoz N, Sebti T, et al. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties. Int J Pharm 2012;428:103–13
- Gué E, Willart J-F, Muschert S, et al. Accelerated ketoprofen release from polymeric matrices: importance of the homogeneity/heterogeneity of excipient distribution. Int J Pharm 2013;457:298–307
- Siepmann J, Siepmann F. Mathematical modeling of drug delivery. Int J Pharm 2008;364:328–43
- Siepmann J, Siepmann F. Modeling of diffusion controlled drug delivery. J Control Release 2012;161:351–62
- McPhillips H, Craig DQM, Royall PG, Hill VL. Characterisation of the glass transition of HPMC using modulated temperature differential scanning calorimetry. Int J Pharm 1999;180:83–90
- Faisant N, Siepmann J, Benoit JP. PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release. Eur J Pharm Sci 2002;15:355–66
- Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev 2012;64:163–74